Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 7Kidney Neoplasms 6Carcinoma, Renal Cell 6Leukemia 4Leukemia, Myelomonocytic, Acute 3Leukemia, Myeloid, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Neuroblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Congenital Abnormalities 2Burkitt Lymphoma 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm Metastasis 1Lymphoma, Mantle-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Hodgkin Disease 1

Interventions

Radiotherapy, Intensity-Modulated 2Fluorouracil 2Cisplatin 2Chemotherapy, Adjuvant 2sargramostim 1dehydroftorafur 1aldesleukin 1Salts 1Radiotherapy, Conformal 1Radiotherapy 1Platinum 1Panitumumab 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Doxepin 1Docetaxel 1Disulfides 1Cetuximab 1Carboplatin 1Bevacizumab 1Allovectin-7 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Tongue Neoplasms × aldesleukin × Clear all
NCT00002702 2013-08-26

Surgery and Radiation Therapy With or Without Interleukin-2 in Treating Patients With Cancer of the Mouth or Oropharynx

National Cancer Institute (NCI)

Phase 3 Unknown
260 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡